Additional support for developing ways of activating Pak1 therapeutically is in the recent report that enrichment of Pak1 specifically in β‐cells promotes insulin biogenesis and reduces cell death, resulting in suppression of diet‐induced glucose intolerance (Ahn et al. 2024). The gene discussed is PAK1; the disease is Glucose intolerance.